Skip to Main Content

Biotech companies make antibody treatments from mice, rabbits, and even camels. So, why not ostriches?

That’s the founding question behind OstriGen, a startup formed last year based on the work of Dr. Yasuhiro Tsukamoto of Kyoto Prefectural University. The idea is fairly simple: Tsukamoto’s lab injects antigens into ostrich hens, who soon develop immunity. When they lay eggs, the yolks are laden with antibodies, which OstriGen then harvests and purifies.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!